News & Events about Verrica Pharmaceuticals Inc.
Globe Newswire
5 months ago
WEST CHESTER, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica or, the Company) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the first patient has been dosed in Part 2 of...
Entrada Therapeutics (NASDAQ:TRDA Get Rating) and Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, ...
Ticker Report
7 months ago
Royal Bank of Canada upgraded shares of Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) from a sector perform rating to an outperform rating in a report released on Monday, Marketbeat reports. The brokerage currently has $11.00 price objective on the stock. Verrica Pharmaceuticals Price ...
Globe Newswire
8 months ago
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
10 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...